These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 18191528)
1. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy. Golcher H; Brunner T; Grabenbauer G; Merkel S; Papadopoulos T; Hohenberger W; Meyer T Eur J Surg Oncol; 2008 Jul; 34(7):756-64. PubMed ID: 18191528 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382 [TBL] [Abstract][Full Text] [Related]
4. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. Huguet F; André T; Hammel P; Artru P; Balosso J; Selle F; Deniaud-Alexandre E; Ruszniewski P; Touboul E; Labianca R; de Gramont A; Louvet C J Clin Oncol; 2007 Jan; 25(3):326-31. PubMed ID: 17235048 [TBL] [Abstract][Full Text] [Related]
5. Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma. Moutardier V; Magnin V; Turrini O; Viret F; Hennekinne-Mucci S; Gonçalves A; Pesenti C; Guiramand J; Lelong B; Giovannini M; Monges G; Houvenaeghel G; Delpero JR Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):437-43. PubMed ID: 15380577 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram. White RR; Kattan MW; Haney JC; Clary BM; Pappas TN; Tyler DS; Brennan MF Ann Surg Oncol; 2006 Nov; 13(11):1485-92. PubMed ID: 17013688 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a ten-year single institution experience. Turrini O; Viret F; Moureau-Zabotto L; Guiramand J; Moutardier V; Lelong B; de Chaisemartin C; Giovannini M; Delpero JR Oncology; 2009; 76(6):413-9. PubMed ID: 19407474 [TBL] [Abstract][Full Text] [Related]
8. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial. Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585 [TBL] [Abstract][Full Text] [Related]
9. [Second-look operation in pancreatic carcinoma previously assessed as unresectable]. Warnick P; Bahra M; Andreou A; Neuhaus P; Glanemann M Zentralbl Chir; 2010 Feb; 135(1):70-4. PubMed ID: 20162503 [TBL] [Abstract][Full Text] [Related]
11. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060 [TBL] [Abstract][Full Text] [Related]
12. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update. van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic hepatic irradiation following curative resection of pancreatic cancer. Hishinuma S; Ogata Y; Tomikawa M; Ozawa I; Inoue K; Katano S; Tsukiyama I J Hepatobiliary Pancreat Surg; 2005; 12(3):235-42. PubMed ID: 15995813 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience. Chao C; Hoffman JP; Ross EA; Torosian MH; Eisenberg BL Am Surg; 2000 Apr; 66(4):378-85; discussion 386. PubMed ID: 10776876 [TBL] [Abstract][Full Text] [Related]
15. Long-term survival (superior to 20 years) after pancreaticoduodenectomy for pancreatic duct adenocarcinoma: report of two cases. Naseef O; Adham M; Hervieu V; Le Borgne J; Partensky C Hepatogastroenterology; 2008; 55(84):1110-1. PubMed ID: 18705340 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant therapy for pancreatic cancer: the Duke experience. White RR; Tyler DS Surg Oncol Clin N Am; 2004 Oct; 13(4):675-84, ix-x. PubMed ID: 15350941 [TBL] [Abstract][Full Text] [Related]
17. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis. Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of unresectable locally advanced pancreatic cancer with combined radiotherapy and chemotherapy]. Jensen HA; Nielsen HO; Jensen JD; Fristrup CW; Nielsen M; Pfeiffer P Ugeskr Laeger; 2008 Feb; 170(8):639-41. PubMed ID: 18364156 [TBL] [Abstract][Full Text] [Related]
19. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Van den Broeck A; Sergeant G; Ectors N; Van Steenbergen W; Aerts R; Topal B Eur J Surg Oncol; 2009 Jun; 35(6):600-4. PubMed ID: 19131205 [TBL] [Abstract][Full Text] [Related]
20. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response. Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]